Access cutting-edge hepatocellular carcinoma treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access hepatocellular carcinoma specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatocellular carcinoma treatment provided free
The purpose of this study is to measure the efficacy and safety of durvalumab intravenous (IV) solution plus bevacizumab IV solution after transarterial radioembolization (Yttrium 90 glass microspheres TARE) in participants with unresectable hepatocellular carcinoma (HCC) amenable to embolization.
Sponsor: AstraZeneca
Check if you qualify for this hepatocellular carcinoma clinical trial in Orlando, FL
If you're searching for hepatocellular carcinoma treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatocellular carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.